Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of Radiofrequency ablation in
metastatic renal cell carcinoma patients with primary tumor less than 5 cm before medical
treatment. Ablation may allow for reduced morbidity and may increase the likelihood of
patients receiving systemic therapy.